在多发性骨髓瘤的化学抗原受体T细胞治疗过程中提供护理服务
Mary Steinbach1, Laura J Zitella2, Erika Florendo3
1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
Seminars in oncology nursing
|September 26, 2023
概括
护士在化学抗原受体T细胞 (CAR-T) 治疗复发性/耐药性多发性骨髓瘤中发挥着至关重要的作用. 他们的专业知识对于患者的资格,教育,管理和毒性管理至关重要,以优化结果.
科学领域:
- 瘤科 护理 护理专业
- 细胞疗法细胞疗法
- 血液学 血液学 血液学
背景情况:
- 化学抗原受体T细胞 (CAR-T) 治疗的批准为复发性/耐药性多发性髓瘤 (RRMM) 患者提供了新的希望.
- 在整个患者旅程中,CAR-T疗法需要专门的护理护理.
- 有效的护理管理对于成功的CAR-T治疗结果至关重要.
研究的目的:
- 提供CAR-T疗法管理过程的概述.
- 描述护士管理RRMM接受CAR-T治疗的患者的实际考虑.
- 突出护理专业人员在CAR-T治疗的所有阶段的重要作用.
主要方法:
- 对RRMM和护理指南的CAR-T疗法的文献综述.
- 在PubMed数据库中搜索相关研究和指导方针.
- 现有文献的综合与专家护士和护士从业人员的实际见解.
主要成果:
- 卡特-T疗法需要与护士和医疗保健提供者合作进行规划,管理和监测.
- 护士是评估患者资格和教育患者和护理人员的重要组成部分.
- 护理专业人员在各种环境中管理各种角色,并有助于识别和管理与CAR-T相关的毒性.
结论:
- 在RRMM的CAR-T治疗过程中,护士是不可或缺的.
- 护理贡献显著优化患者护理和治疗结果.
- 加强护理支持是克服CAR-T治疗复杂性的关键.
相关概念视频
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
Myocarditis IV: Nursing Management
13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K


